Landon Hope
Resident Physician
Also affiliated: Texas Tech University (2020–2023); University Medical Center (2020); Texas Tech University Health Sciences Center (2020–2023)
College of Medicine Administration
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Landon Hope's research focuses on dermatological conditions, particularly keratinocyte carcinomas and their treatment. Hope has investigated predictors for the number of stages required in Mohs micrographic surgery for these skin cancers, and analyzed Mohs Appropriate Use Criteria Scores in relation to treatment outcomes for keratinocyte carcinoma. Additionally, Hope's work includes medical case reports on unusual dermatological presentations, such as a late-onset pseudolymphomatous reaction to blue tattoo pigment and a dysmorphic fungal infection mimicking blastomycosis. Other published work examines the impact of a focused factory on intraoperative costs in knee replacement surgery and the effect of tube feeding on glucose control in burn patients.
Metrics
- h-index: 2
- Publications: 9
- Citations: 10
Positions
-
Resident Physician publications 2023University of Arkansas for Medical Sciences College of Medicine Administration Institutional directory
Selected Publications
-
Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors (2023)
-
Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages (2023)
Collaboration Network
Top Collaborators
- Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages
- Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors
- Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages
- Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors
- Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages
- Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors
Similar Researchers
Based on overlapping research topics